|
Volumn 30, Issue 3, 2005, Pages 280-282
|
Effect of simvastatin on cardiac fibrosis in patients with essential hypertension
|
Author keywords
Collagen; Hypertension; Moycardial fibrosis; Simvastatin; TGF 1
|
Indexed keywords
BENAZEPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;
PROCOLLAGEN TYPE 4 AMINOPROPEPTIDE;
SIMVASTATIN;
TRANSFORMING GROWTH FACTOR BETA1;
UNCLASSIFIED DRUG;
ARTICLE;
BLOOD FLOW VELOCITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLE;
DOPPLER ECHOGRAPHY;
DRUG EFFECT;
ESSENTIAL HYPERTENSION;
HEART LEFT VENTRICLE FUNCTION;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART LEFT VENTRICLE MASS;
HEART MUSCLE FIBROSIS;
HEART VENTRICLE SEPTUM;
HUMAN;
MAJOR CLINICAL STUDY;
MEAN ARTERIAL PRESSURE;
MITRAL VALVE;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BENZAZEPINES;
DRUG THERAPY, COMBINATION;
FEMALE;
FIBROSIS;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
MYOCARDIUM;
SIMVASTATIN;
|
EID: 22244471385
PISSN: 16727347
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (7)
|